Reviews

We know that scientists rely on review papers to keep current with expert perspectives on their field. That’s why we include high-impact, comprehensive prostate cancer review papers in every issue of Prostate Cell News. We then archive these hand-selected review papers here on the Prostate Cell News reviews board. Sort through the list by title, journal, or date, or just browse through them all to catch up with the latest perspectives in prostate cancer research. You can also submit a recent review paper to our editors, and we’ll try to include it in the next issue of Prostate Cell News.

Title   Journal   Publication Date   Newsletter Issue  
Circulating Steroid Hormone Variations Throughout Different Stages of Prostate Cancer
Snaterse, G; Visser, J; Arlt, W; Hofland, J
Endocr Relat Cancer 2017-09-18 8.36 | Sep 22
WNT Signaling in Prostate Cancer
Murillo-Garzón, V; Kypta, R
Nat Rev Urol 2017-09-12 8.35 | Sep 15
Extracellular Vesicles for Personalized Therapy Decision Support in Advanced Metastatic Cancers and Its Potential Impact for Prostate Cancer
Soekmadji, C; Corcoran, NM; Oleinikova, I; Jovanovic, L; The Australian Prostate Cancer Collaboration BioResource; Ramm, GA; Nelson, CC; Jenster, G; Russell, PJ
Prostate 2017-08-29 8.35 | Sep 15
Ethnicity and ERG Frequency in Prostate Cancer
Sedarsky, J; Degon, M; Srivastava, S; Dobi, A
Nat Rev Urol 2017-09-05 8.34 | Sep 8
Managing High-Grade Prostatic Intraepithelial Neoplasia (HGPIN) and Atypical Glands on Prostate Biopsy
Tosoian, JJ; Alam, R; Ball, MW; Carter, HB; Epstein, JI
Nat Rev Urol 2017-08-31 8.33 | Sep 1
Implications of BCL-2 and Its Interplay with Other Molecules and Signaling Pathways in Prostate Cancer Progression
Kim, JH; Lee, H; Shin, EA; Kim, DH; Choi, JB; Kim, SH
Expert Opin Ther Targets 2017-08-23 8.32 | Aug 25
Implications of Bcl-2 and Its Interplay with Other Molecules and Signaling Pathways in Prostate Cancer Progression
Kim, JH; Lee, H; Shin, EA; Kim, DH; Choi, JB; Kim, SH
Expert Opin Ther Targets 2017-08-17 8.31 | Aug 18
Tissue Control of Androgen Action: The Ups and Downs of Androgen Receptor Expression
Hunter, I; Hay, CW; Esswein, B; Watt, K; McEwen, IJ
Mol Cell Endocrinol 2017-08-05 8.30 | Aug 11
Tumor Organoids as a Pre-Clinical Cancer Model for Drug Discovery
Weeber, F; Ooft, SN; Dijkstra, KK; Voest, EE
Cell Chem Biol 2017-07-27 8.29 | Aug 4
Recent Advances in Circulating Tumor Cells and Cell-Free DNA in Metastatic Prostate Cancer: A Review
Parimi, S; Ko, JJ
Expert Rev Anticancer Ther 2017-07-24 8.28 | Jul 28
Overcoming Oncogenic Mediated Tumor Immunity in Prostate Cancer
Bryant, G; Wang, L; Mulholland, DJ
Int J Mol Sci 2017-07-17 8.27 | Jul 21
Connexins, Important Players in the Dissemination of Prostate Cancer Cells
Boucher, J; Monvoisin A; Vix, J; Mesnil, M; Thuringer, D; Debiais, F; Cronier, L
Biochim Biophys Acta 2017-07-08 8.26 | Jul 14
Telomeres and Telomerase in Prostate Cancer Development and Therapy
Graham, MK; Meeker, A
Nat Rev Urol 2017-07-04 8.25 | Jul 7
Dose Considerations for Anti-Cancer Drugs in Metastatic Prostate Cancer
Crumbaker, M; Gurney, H
Prostate 2017-06-26 8.24 | Jun 30
The Stem Cell Factor (SCF)/C-KIT Signaling in Testis and Prostate Cancer
Cardoso, HJ; Figueira, MI; Socorro, S
J Cell Commun Signal 2017-06-27 8.24 | Jun 30
Exosomes in Diagnosis and Therapy of Prostate Cancer
Pan, J; Ding, M; Xu, K; Yang, C; Mao, L
Oncotarget 2017-06-16 8.23 | Jun 23
The Role of Peroxisome Proliferator-Activated Receptor Gamma in Prostate Cancer
Elix, C; Pal, SK; Jones, JO
Asian J Androl 2017-06-09 8.22 | Jun 16
27-Hydroxycholesterol: A Novel Player in Molecular Carcinogenesis of Breast and Prostate Cancer
Marwarha, G; Raza, S; Hammer, K; Ghribi, O
Chem Phys Lipids 2017-06-03 8.21 | Jun 9
Myeloid-Derived Cells in Prostate Cancer Progression: Phenotype and Prospective Therapies
Lopez-Bujanda, Z; Drake, CG
J Leukoc Biol 2017-05-26 8.20 | Jun 2
Magnetic Nanoformulations for Prostate Cancer
Chowdhury, P; Roberts, AM; Khan, S; Hafeez, BB; Chauhan, SC; Jaggi, M; Yallapu, MM
Drug Discov Today 2017-05-16 8.19 | May 26
Advances in Medical Imaging for the Diagnosis and Management of Common Genitourinary Cancers
Bagheri, MH; Ahlman, MA; Lindenberg, L; Turkbey, B; Lin, J; Cahid Civelek, A; Malayeri, AA; Agarwal, PK; Choyke, PL; Folio, LR; Apolo, AB
Urol Oncol 2017-05-12 8.18 | May 19
Cellular Constituents of the Prostate Stroma: Key Contributors to Prostate Cancer Progression and Therapy Resistance
Levesque, C; Nelson, PS
Cold Spring Harb Perspect Med 2017-05-10 8.17 | May 12
Immunotherapy in Genitourinary Malignancies
Mehta, K; Patel, K; Parikh, RA
J Hematol Oncol 2017-04-24 8.16 | May 5
The ETS Family of Oncogenic Transcription Factors in Solid Tumors
Sizemore, GM; Pitarresi, JR; Balakrishnan, S; Ostrowski, MC
Nat Rev Cancer 2017-04-28 8.15 | Apr 28
Cellular Determinants and Microenvironmental Regulation of Prostate Cancer Metastasis
Rycaj, K; Li, H; Zhou, J; Chen, X; Tang, DG
Semin Cancer Biol 2017-04-11 8.14 | Apr 21
Extracellular Vesicles for Liquid Biopsy in Prostate Cancer: Where Are We and Where Are We Headed?
Minciacchi, VR; Zijlstra, A; Rubin, MA; Di Vizio, D
Prostate Cancer Prostatic Dis 2017-04-04 8.13 | Apr 7
Brachytherapy for Patients with Prostate Cancer: American Society of Clinical Oncology/Cancer Care Ontario Joint Guideline Update
Chin, J; Rumble, RB; Kollmeier, M; Heath, E; Efstathiou, J; Dorff, T; Berman, B; Feifer, A; Jacques, A; Loblaw, DA
J Clin Oncol 2017-03-27 8.12 | Mar 31
Chimeric Antigen Receptors (CARs)–a Cell and Gene Therapy Perspective
Riviere, I; Sadelain, M
Mol Ther 2017-03-31 8.12 | Mar 31
Low-Risk Prostate Cancer: Identification, Management, and Outcomes
Moschini, M; Carroll, PR; Eggener, SE; Epstein, JI; Graefen, M; Montironi, R; Parker, C
Eur Urol 2017-03-19 8.11 | Mar 24
Immune Mediators in the Tumor Microenvironment of Prostate Cancer
Dai, J; Lu, Y; Roca, H; Keller, JM; Zhang, J; McCauley, LK; Keller, ET
Chin J Cancer 2017-03-14 8.10 | Mar 17
Long Non-Coding RNA as Potential Biomarker for Prostate Cancer: Is It Making a Difference?
Deng, J; Tang, J; Wang, G; Zhu, YS
Int J Environ Res Public Health 2017-03-07 8.09 | Mar 10
Radiolabeled PSMA Small Molecule Inhibitors
Will, L; Sonni, I; Kopka, K; Kratochwil, C; Giesel, FL; Haberkorn, U
Q J Nucl Med Mol Imaging 2017-02-17 8.08 | Mar 3
Meta-Analysis of Metabolic Syndrome and Prostate Cancer
Gacci, M; Russo, GI; De Nunzio, C; Sebastianelli, A; Salvi, M; Vignozzi, L; Tubaro, A; Morgia, G; Serni, S
Prostate Cancer Prostatic Dis 2017-02-21 8.07 | Feb 24
Revisiting the Role of Wnt/β-Catenin Signaling in Prostate Cancer
Schneider, JA; Logan, SK
Mol Cell Endocrinol 2017-02-09 8.06 | Feb 17
Comparing the Rules of Engagement of Androgen and Glucocorticoid Receptors
Claessens, F; Joniau, S; Helsen, C
Cell Mol Life Sci 2017-02-06 8.05 | Feb 10
Immune Modulation by Androgen Deprivation and Radiation Therapy: Implications for Prostate Cancer Immunotherapy
Kalina, JL; Neilson, DS; Comber, AP; Rauw, JM; Alexander, AS; Vergidis, J; Lum, JJ
Cancers 2017-01-27 8.04 | Feb 3
Stromal Androgen Receptor in Prostate Cancer Development and Progression
Leach, DA; Buchanan, G
Cancers 2017-01-22 8.03 | Jan 27
Regulation of PI3K Effector Signaling in Cancer by the Phosphoinositide Phosphatases
Rodgers, SJ; Ferguson, D; Mitchell, C; Ooms, L
Biosci Rep 2017-01-12 8.02 | Jan 20
Androgen Receptor Splice Variants and Prostate Cancer: From Bench to Bedside
Wadosky, KM; Koochekpour, S
Oncotarget 2017-01-06 8.01 | Jan 12
Prostate cancer, PI3K, PTEN and Prognosis
Wise, HM; Hermida, MA; Leslie, NR
Conn Sci 2017-01-05 8.01 | Jan 12
Extranuclear Partners of Androgen Receptor: At the Crossroads of Proliferation, Migration, and Neuritogenesis
Castoria, G; Auricchio, F; Migliaccio, A
FASEB J 2016-12-28 8.00 | Jan 6
Exosomal MicroRNAs in Liquid Biopsies: Future Biomarkers for Prostate Cancer
Valentino, A; Reclusa, P; Sirera, R; Giallombardo, M; Camps, C; Pauwels, P; Crispi, S; Rolfo, C
Clin Transl Oncol 2017-01-04 8.00 | Jan 6
Histone Demethylase Lysine Demethylase 5B in Development and Cancer
Han, M; Xu, W; Cheng, P; Jin, H; Wang, X
Oncotarget 2016-12-10 7.46 | Dec 16
Blood-Based and Urinary Prostate Cancer Biomarkers: A Review and Comparison of Novel Biomarkers for Detection and Treatment Decisions
Hendriks, RJ; van Oort, IM; Schalken, JA
Prostate Cancer Prostatic Dis 2016-12-06 7.45 | Dec 9
Investigational Serine/Threonine Kinase Inhibitors against Prostate Cancer Metastases
Festuccia, C
Expert Opin Investig Drugs 2016-11-25 7.44 | Dec 2
The Role of GATA2 in Lethal Prostate Cancer Aggressiveness
Rodriguez-Bravo, V; Carceles-Cordon, M; Hoshida, Y; Cordon-Cardo, C; Galsky, MD; Domingo-Domenech, J
Nat Rev Urol 2016-11-22 7.43 | Nov 25
Circulating Tumor Cells as Biomarkers of Prostate, Bladder, and Kidney Cancer
Gorin, MA; Verdone, JE; van der Toom, E; Bivalacqua, TJ; Allaf, ME; Pienta, KJ
Nat Rev Urol 2016-11-22 7.43 | Nov 25
Androgen Synthesis in Prostate Cancer: Do All Roads Lead to Rome?
Stuchbery, R; McCoy, PJ; Hovens, CM; Corcoran, NM
Nat Rev Urol 2016-11-08 7.42 | Nov 18
Prostate Cancer: Developing Novel Approaches to Castration-Sensitive Disease
Francini, E; Taplin ME
Cancer 2016-11-01 7.41 | Nov 4
The Impact of Local Treatment of the Primary Tumor Site in Node Positive and Metastatic Prostate Cancer Patients
Moschini, M; Soria, F; Briganti, A; Shariat, SF
Prostate Cancer Prostatic Dis 2016-10-25 7.40 | Oct 28
The Current Evidence on Statin Use and Prostate Cancer Prevention: Are We There Yet?
Alfaqih, MA; Allott, EH; Hamilton, RJ; Freeman, MR; Freedland, SJ
Nat Rev Urol 2016-10-25 7.40 | Oct 28
p62 in Cancer: Signaling Adaptor Beyond Autophagy
Moscat, J; Michael Karin; Maria T. Diaz-Meco
Cell 2016-10-20 7.39 | Oct 21
Androgen Receptor Variation Affects Prostate Cancer Progression and Drug Resistance
McCrea E; Sissung, TM; Price, DK; Chau, CH; Figg, WD
Pharmacol Res 2016-10-07 7.38 | Oct 14
Alternative Splicing and Cell Survival: From Tissue Homeostasis to Disease
Paronetto, MP; Passacantilli, I; Sette, C
Cell Death Differ 2016-09-30 7.37 | Oct 7
Inflammatory Mediators in the Development and Progression of Benign Prostatic Hyperplasia
De Nunzio, C; Presicce, F; Tubaro, A
Nat Rev Urol 2016-09-30 7.37 | Oct 7
The Cohesive Metastasis Phenotype in Human Prostate Cancer
Harryman, WL; Hinton, JP; Rubenstein, CP; Singh, P; Nagle, RB; Parker, SJ; Knudsen, BS; Cress, AE
Biochim Biophys Acta 2016-09-24 7.36 | Sep 30
CD147 and Prostate Cancer: A Systematic Review and Meta-Analysis
Peng, F; Li, H; Ning, Z; Yang, Z; Li, H; Wang, Y; Chen, F; Wu, Y
PLoS One 2016-09-29 7.36 | Sep 30
Epigenetic Modulators as Therapeutic Targets in Prostate Cancer
Graça, I; Pereira-Silva, E; Henrique, R; Packham, G; Crabb, SJ; Jerónimo, C
Clin Epigenetics 2016-09-15 7.34 | Sep 23
Signatures of Prostate-Derived Ets Factor (PDEF) in Cancer
Mahajan, N
Tumour Biol 2016-09-10 7.34 | Sep 16
Importance of Estrogenic Signaling and Its Mediated Receptors in Prostate Cancer
Lau, KM; To, KF
Int J Mol Sci 2016-08-31 7.33 | Sep 9
Acute Severe Ulcerative Colitis: From Pathophysiology to Clinical Management
Hindryckx, P; Jairath, V; D’Haens, G
Nat Rev Gastroenterol Hepatol 2016-09-01 2.32 | Sep 2
The Interplay Between Cell Signaling and the Mevalonate Pathway in Cancer
Mullen, PJ; Yu, R; Longo, J; Archer, MC; Penn, LZ
Nat Rev Cancer 2016-08-26 7.31 | Aug 26
The Role of α1-Adrenoceptor Antagonists in the Treatment of Prostate and Other Cancers
Batty, M; Pugh, R; Rathinam, I; Simmonds J; Walker, E; Forbes, A; Anoopkumar-Dukie, S; McDermott, CM; Spencer, B; Christie, D; Chess-Williams, R
Int J Mol Sci 2016-08-16 7.30 | Aug 19
Hypertension and Risk of Prostate Cancer: A Systematic Review and Meta-Analysis
Liang, Z; Xie, B; Li, J; Wang, X; Wang, S; Meng, S; Ji, A; Zhu, Y; Xu, X; Zheng, X; Xie, L
Sci Rep 2016-08-11 7.29 | Aug 12
A 3D Toolbox to Enhance Physiological Relevance of Human Tissue Models
Picollet-D’hahan, N; Dolega, ME; Liguori, L; Marquette, C; Le Gac, S; Gidrol, X; Martin, DK
Trends Biotechnol 2016-08-03 7.28 | Aug 5
Liquid Biopsy: Ready to Guide Therapy in Advanced Prostate Cancer?
Hegemann, M; Stenzl, A; Bedke, J; Chi, KN; Black, PC; Todenhöfer, T
BJU Int 2016-07-19 7.27 | Jul 29
Drug Discovery in Advanced Prostate Cancer: Translating Biology into Therapy
Yap, TA; Smith, AD Paul Workman &; Ferraldeschi, R; Al-Lazikani, B; Workman, P; de Bono, JS
Nat Rev Drug Discov 2016-07-22 7.26 | Jul 22
TRPM8 Puts the Chill on Prostate Cancer
Grolez, GP; Gkika, D
Pharmaceuticals 2016-07-09 7.25 | Jul 15
Aberrant Lipid Metabolism Promotes Prostate Cancer: Role in Cell Survival under Hypoxia and Extracellular Vesicles Biogenesis
Deep, G; Schlaepfer, IR
Int J Mol Sci 2016-07-02 7.24 | Jul 8
A Comprehensive Review of Genomic Landscape, Biomarkers and Treatment Sequencing in Castration-Resistant Prostate Cancer
Seisen, T; Rouprêt, M; Gomez, F; Malouf, GG; Shariat, SF; Peyronnet, B; Spano, JP; Cancel-Tassin, G; Cussenot, O
Cancer Treat Rev 2016-06-15 7.23 | Jun 24
Androgen Receptor Targeted Therapies in Castration-Resistant Prostate Cancer: Bench to Clinic
Imamura, Y; Sadar, MD
Int J Urol 2016-06-14 7.22 | Jun 17
The Roles of MicroRNAs in the Progression of Castration-Resistant Prostate Cancer
Kojima, S; Goto, Y; Naya, Y
J Hum Genet 2016-06-09 7.21 | Jun 10
Deciphering the Function of Non-Coding RNAs in Prostate Cancer
Ramalho-Carvalho, J; Fromm, B; Henrique, R; Jerónimo, C
Cancer Metastasis Rev 2016-05-25 7.20 | Jun 3
Oncolytic Virotherapy for Urological Cancers
Delwar, Z; Zhang, K; Rennie, PS; Jia, W
Nat Rev Urol 2016-05-24 7.19 | May 27
Diagnostic, Prognostic and Predictive Value of Cell-Free miRNAs in Prostate Cancer: A Systematic Review
Endzelins, E; Melne, V; Kalnina, Z; Lietuvietis, V; Riekstina, U; Llorente, A; Line, A
Mol Cancer 2016-05-18 7.19 | May 27
Androgen Receptor Variant-Driven Prostate Cancer: Clinical Implications and Therapeutic Targeting
Antonarakis, ES; Armstrong, AJ; Dehm, SM; Luo, J
Prostate Cancer Prostatic Dis 2016-05-17 7.19 | May 20
MRI-Guided Prostate Adaptive Radiotherapy – A Systematic Review
McPartlin, AJ; Li, XA; Kershaw, LE; Heide, U; Kerkmeijer, L; Lawton, C; Mahmood, U; Pos, F; van, As, N; van, Herk, M; Vesprini, D; van, der, Voort, van, Zyp, J; Tree, A; Choudhury, A
Radiother Oncol 2016-05-06 7.17 | May 13
Progesterone Receptor in the Prostate: A Potential Suppressor for Benign Prostatic Hyperplasia and Prostate Cancer
Chen, R; Yu, Y; Dong, X
J Steroid Biochem Mol Biol 2016-04-25 7.16 | May 6
A Comprehensive Review of the Role of Zinc in Normal Prostate Function and Metabolism; and Its Implications in Prostate Cancer
Costello, LC; Franklin, RB
Arch Biochem Biophys 2016-04-27 7.16 | May 6
The Importance of DNA Methylation in Prostate Cancer Development
Massie, CE; Mills, IG; Lynch, AG
J Steroid Biochem Mol Biol 2016-04-23 7.15 | Apr 29
The Role of Glycans in the Development and Progression of Prostate Cancer
Munkley, J; Mills, IG; Elliott, DJ
Nat Rev Urol 2016-04-19 7.14 | Apr 22
The Cross-Talk between Wnt/β-Catenin and CIP2A/Plk1 Signaling in Prostate Cancer: Promising Therapeutic Implications
Cristóbal, I; Rojo, F; Madoz-Gurpide, J; García-Foncillas, J
Mol Cell Biol 2016-04-18 7.14 | Apr 22
Targeting Persistent Androgen Receptor Signaling in Castration-Resistant Prostate Cancer
Graham, L; Schweizer, MT
Med Oncol 2016-04-04 7.12 | Apr 8
Molecular Mechanisms of Curcumin and Its Semisynthetic Analogues in Prostate Cancer Prevention and Treatment
Jordan, BC; Mock, CD; Thilagavathi, R; Selvam, C
Life Sci 2016-03-23 7.11 | Apr 1
Dissecting the Role of microRNAs in Prostate Cancer Metastasis: Implications for the Design of Novel Therapeutic Approaches
Doldi, V; Pennati, M; Forte, B; Gandellini, P; Zaffaroni, N
Cell Mol Life Sci 2016-03-12 7.10 | Mar 18
Enhancing Active Surveillance of Prostate Cancer: The Potential of Exercise Medicine
Galvão, DA; Taaffe, DR; Spry, N; Gardiner, RA; Taylor, R; Risbridger, GP; Frydenberg, M; Hill, M; Chambers, SK; Stricker, P; Shannon, T; Hayne, D; Zopf, E; Newton, RU
Nat Rev Urol 2016-03-08 7.09 | Mar 11
Active Surveillance for Prostate Cancer: Current Evidence and Contemporary State of Practice
Tosoian, JJ; Carter, HB; Lepor, A; Loeb, S
Nat Rev Urol 2016-03-08 7.09 | Mar 11
New Insights into the Androgen Biotransformation in Prostate Cancer: A Regulatory Network Among Androgen, Androgen Receptors and UGTs
Qin, X; Liu, M; Wang, X
Pharmacol Res 2016-02-26 7.08 | Mar 4
Current Use of PSMA-PET in Prostate Cancer Management
Maurer, T; Eiber, M; Schwaiger; Gschwend, JE
Nat Rev Urol 2016-02-23 7.07 | Feb 26
Clonality of Localized and Metastatic Prostate Cancer
Boutros, PC; Fraser, M; van, der, Kwast, T; Bristow, RG
Curr Opin Urol 2016-02-16 7.06 | Feb 19
Role of Taxanes in Advanced Prostate Cancer
Cassinello, J; Carballido Rodríguez, J; Antón Aparicio, L
Clin Transl Oncol 2016-02-08 7.05 | Feb 12
Regulation of Prostate Cancer Progression by the Tumor Microenvironment
Shiao, SL; Chu, GC; Chung, LW
Cancer Lett 2016-01-28 7.04 | Feb 5
The Importance of Non-Nuclear AR Signaling in Prostate Cancer Progression and Therapeutic Resistance
Zarif, JC; Miranti, CK
Cell Signal 2016-01-29 7.04 | Feb 5
Active Surveillance for Prostate Cancer: A Narrative Review of Clinical Guidelines
Bruinsma, SM; Bangma, CH; Carroll, PR; Leapman, MS
Nat Rev Urol 2016-01-27 7.03 | Jan 29
Prospects for the Use of Ipilimumab in Treating Advanced Prostate Cancer
Wei, XX; Fong, L; Small, EJ
Expert Opin Biol Ther 2016-01-25 7.03 | Jan 29
Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia and Metabolic Syndrome
Vignozzi, L; Gacci, M & Maggi, M
Nat Rev Urol 2016-01-12 7.02 | Jan 22
miRNAs as Novel Biomarkers in the Management of Prostate Cancer
Filella, X; Foj, L
Clin Chem Lab Med 2016/01/09 7.01 | Jan 15
Testosterone Therapy in Men with Prostate Cancer
Kaplan, AL; Hu, JC; Morgentaler, A; Mulhall, JP; Schulman, CC; Montorsi, F
Eur Urol 2015-12-21 7.00 | Jan 8
Prostate Cancer in Men of African Origin
McGinley, KF; Tay, KJ; Moul, JW
Nat Rev Urol 2015-12-31 7.00 | Jan 8
Targeting Androgen/Estrogen Receptors Crosstalk in Cancer
Karamouzis, VM; Papavassiliou, KA; Adamopoulos, C; Papavassiliou, AG
Trends Cancer 2015-12-31 7.00 | Jan 8
Androgen–Glucocorticoid Interactions in the Era of Novel Prostate Cancer Therapy
Narayanan, S; Srinivas, S; Feldman, D
Nat Rev Urol 2015-12-08 6.48 | Dec 18
Immunotherapy in Prostate Cancer: Challenges and Opportunities
Noguchi, M; Koga, N; Moriya, F; Itoh, K
Immunotherapy 2015-12-07 6.47 | Dec 11
Linking Obesogenic Dysregulation to Prostate Cancer Progression
Taylor, RA; Lo, J; Ascui, N; Watt, MJ
Endocr Connect 2015-12-01 6.47 | Dec 11
Virus Encoded Circulatory miRNAs for Early Detection of Prostate Cancer
Kim, J; Yun, SJ; Kim, WJ
BMC Urol 2015-11-26 6.46 | Dec 4
Persistent Androgen Receptor Addiction in Castration-Resistant Prostate Cancer
Schweizer, MT; Yu, EY
J Hematol Oncol 2015-11-13 6.45 | Nov 27
Epithelial–Mesenchymal Transition in Prostatic Disease
Broster, SA; Kyprianou, N
Future Oncol 2015-11-09 6.44 | Nov 20
Emerging Mechanisms of Resistance to Androgen Receptor Inhibitors in Prostate Cancer
Watson, PA; Arora, VK; Sawyers, CL
Nat Rev Cancer 2015-11-13 6.43 | Nov 13
Notch Signaling in Prostate Cancer: Refining a Therapeutic Opportunity
Su, Q; Xin, L
Histol Histopathol 2015-11-02 6.42 | Nov 6
Prostate Cancer Stem Cells: The Role of Androgen and Estrogen Receptors
Di Zazzo, E; Galasso, G; Giovannelli, P; Di Donato, M; Di Santi, A; Cernera, G; Rossi, V; Abbondanza, C; Moncharmont, B; Sinisi, AA; Castoria, G; Migliaccio, A
Oncotarget 2015-10-24 6.41 | Oct 30
The Biology and Clinical Implications of Prostate Cancer Dormancy and Metastasis
Morrissey, C; Vessella, RL; Lange, PH; Lam, HM
J Mol Med 2015-10-21 6.40 | Oct 23
P-Cadherin and the Journey to Cancer Metastasis
Vieira, AF; Paredes, J
Mol Cancer 2015-10-06 6.39 | Oct 16
MicroRNA in Prostate Cancer
Khanmi, K; Ignacimuthu, S; Paulraj, MG
Clin Chim Acta 2015-09-27 6.38 | Oct 9
Clinical Implications of Hedgehog Pathway Signaling in Prostate Cancer
Antonarakis, E; Suzman, D
Cancers 2015-09-25 6.37 | Oct 2
Intermittent vs Continuous Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and Meta-Analysis
Magnan, S; Zarychanski, R; Pilote, L; Bernier, L; Shemilt, M; Vigneault, E; Fradet, V; Turgeon, AF
JAMA Oncol 2015-09-17 6.36 | Sep 25
The Origin of Prostate Metastases: Emerging Insights
Montironi, R; Santini, D; Piva, F; Santoni, M
Cancer Metastasis Rev 2015-09-12 6.35 | Sep 18
Stem Cells in Genetically-Engineered Mouse Models of Prostate Cancer
Shen, M; Shibata, M
Endocr Relat Cancer 2015-09-04 6.34 | Sep 11
The Many Ways to Make a Luminal Cell and a Prostate Cancer Cell
Goldstein, AS; Strand, DW
Endocr Relat Cancer 2015-08-25 6.33 | Sep 4
Androgen Receptor and Prostate Cancer Stem Cells: Biological Mechanisms and Clinical Implications
Tang, D; Deng, Q
Endocr Relat Cancer 2015-08-18 6.31 | Aug 21
Stem Cells as Hormone Targets that Lead to Increased Cancer Susceptibility
Prins, GS; Calderon-Gierszal, EL; Hu, WY
Endocrinology 2015-08-04 6.30 | Aug 14
The Insulin-Like Growth Factor (IGF) Axis as an Anticancer Target in Prostate Cancer
Heidegger, I; Massoner, P; Sampson, N; Klocker, H
Cancer Lett 2015-07-28 6.29 | Aug 7
Metformin and Prostate Cancer Stem Cells: A Novel Therapeutic Target
Venkateswaran, V; Klotz, LH; Mayer, MJ
Prostate Cancer Prostatic Dis 2015-07-28 6.28 | Jul 31
MicroRNA in Prostate Cancer: Practical Aspects
Patil, PA; Magi-Galluzzi, C
Histol Histopathol 2015-07-17 6.27 | Jul 24
Metabolomic Profiling for the Identification of Novel Diagnostic Markers in Prostate Cancer
Lucarelli, G; Rutigliano, M; Galleggiante, V; Giglio, A; Palazzo, S; Ferro, M; Simone, C; Bettocchi, C; Battaglia, M; Ditonno, P
Expert Rev Mol Diagn 2015-07-15 6.26 | Jul 17
The Genomic Evolution of Human Prostate Cancer
Neal, DE; Mitchell, T
Br J Cancer 2015-06-30 6.24 | Jul 3
Circulating Long Noncoding RNA as a Potential Target for Prostate Cance
Yang, J; Huang, YQ; Yu, J; Su, YJ
Int J Mol Sci 2015-06-11 6.23 | Jun 26
Using Circulating Tumor Cells to Inform on Prostate Cancer Biology and Clinical Utility
Armstrong, A; Garcia-Blanco, M; Gregory, S; Li, J
Crit Rev Clin Lab Sci 2015-06-16 6.22 | Jun 19
Determinants of Receptor- and Tissue-Specific Actions in Androgen Signaling
Pihlajamaa, P; Sahu, B; Janne, OA
Endocr Rev 2015-06-08 6.21 | Jun 12
Anticancer Properties of Carotenoids in Prostate Cancer: A Review
Soares, ND; Teodoro, AJ; Lotsch, PF; Granjeiro, JM; Borojevic, R
Histol Histopathol 2015-06-07 6.21 | Jun 12
STIM and Orai Proteins as Novel Targets for Cancer Therapy
Motiani, R; Trebak, M; Vashisht, A
Am J Physiol Cell Physiol 2015-05-27 6.19 | May 29
MicroRNAs Targeting Prostate Cancer Stem Cells
Gao, WQ; Chang, YL; Fang, YX
Exp Biol Med 2015-05-12 6.18 | May 22
Targeted Therapies for Prostate Cancer
Roviello, G; Laera, L; Fiaschi, AI; Francini, E; Petrioli, R
Cancer Invest 2015-05-07 6.17 | May 15
Regulation of Tumor Cell Plasticity by the Androgen Receptor in Prostate Cancer
Zoubeidi, A; Ketola, K; Davies, AH; Bishop, JL
Endocr Relat Cancer 2015-05-01 6.16 | May 8
The Oncogene ERG: A Key Factor in Prostate Cancer
Ladomery, MR; Adamo, P
Oncogene 2015-04-27 6.15 | May 1
Characterization of the Roles of Suppressor of Cytokine Signaling-3 in Prostate Cancer Development and Progression
Fu, X; Ren; L; Chen, J; Liao, K; Fu, Y; Qian, X; Xiao, J
Asia Pac J Clin Oncol 2015-04-20 6.14 | Apr 24
Regulation of Vascular Endothelial Growth Factor (VEGF) in Prostate Cancer
Mongang, N; de Brot, S
Endocr-Relat Cancer 2015-04-13 6.13 | Apr 17
Quercetin in Prostate Cancer: Chemotherapeutic and Chemopreventive Effects, Mechanisms and Clinical Application Potential
Yang, F; Song, L; Wang, H; Wang, J; Xu, Z; Xing, N
Oncol Rep 2015-03-31 6.12 | Apr 10
Physical Activity and Its Mechanistic Effects on Prostate Cancer
Wekesa, A; Harrison, M; Watson, RW
Prostate Cancer Prostatic Dis 2015-03-24 6.11 | Mar 27
Implications of Ubiquitin Ligases in Castration-Resistant Prostate Cancer
Qi, J; Fan, L; Hussain, A
Curr Opin Oncol 2015-03-25 6.11 | Mar 27
Inflammation and Prostate Cancer: Friends or Foe?
Taverna, G; Pedretti, E; Di Caro, G; Borrino, EM; Marchesi, F; Grizzi, F
Inflamm Res 2015-03-19 6.10 | Mar 20
Roles of Ubiquitination and SUMOylation on Prostate Cancer: Mechanisms and Clinical Implications
Chen, Z; Lu, W
Int J Mol Sci 2015-02-27 6.09 | Mar 13
Notch Signaling in the Prostate: Critical Roles during Development and in the Hallmarks of Prostate Cancer Biology
Deng, G; Ma, L; Meng, Q; Ju, X; Jiang, K; Jiang, P; Yu, Z
J Cancer Res Clin Oncol 2015-03-04 6.08 | Mar 6
Enzalutamide: A Review of Its Use in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer
Keating, GM
Drugs Aging 2015-02-25 6.07 | Feb 27
Current and Emerging Immunotherapies for Castration-Resistant Prostate Cancer
Saad, F; Miller, K
Urology 2015-02-20 6.07 | Feb 27
Prostate Cancer Vaccines: The Long Road to Clinical Application
Baxevanis, CN; Papamichail, M; Perez, SA
Cancer Immunol Immunother 2015-02-19 6.06 | Feb 20
Molecular Imaging of Prostate Cancer: Translating Molecular Biology Approaches into the Clinical Realm
Vargas, HA; Grimm, J; Donati, OF; Sala, E; Hricak, H
Eur Radiol 2015-02-20 6.06 | Feb 20
Dietary Polyphenols in Prevention and Treatment of Prostate Cancer
Lall, RK; Syed, DN; Adhami, VM; Khan, MI; Mukhtar, H
Int J Mol Sci 2015-02-03 6.05 | Feb 13
Leading Causes of Castration-Resistant Prostate Cancer
Lu, M; Lu, H; Kong, Q
Expert Rev Anticancer Ther 2015/02/03 6.04 | Feb 6
Functional Significance of Aberrantly Expressed MicroRNAs in Prostate Cancer
Goto, Y; Kurozumi, A; Enokida, H; Ichikawa, T; Seki, N
Int J Urol 2015-01-20 6.03 | Jan 30
Clinical Significance of ERβ in Breast and Prostate Cancer from Biological Aspects
Omoto, Y; Iwase, H
Cancer Sci 2015-01-22 6.02 | Jan 23
Immunotherapy for Castration-Resistant Prostate Cancer: Progress and New Paradigms
Quinn, DI; Shore, ND; Egawa, S; Gerritsen, WR; Fizazi, K
Urol Oncol 2015-01-06 6.01 | Jan 16
Role of Diet in Prostate Cancer: The Epigenetic Link
Labb&eaccute;, DP; Zadra, G; Ebot, EM; Kantoff, PW; Loda, M; Brown, M
Oncogene 2014-12-22 6.00 | Jan 9
Androgen-Targeted Therapy-Induced Epithelial Mesenchymal Plasticity and Neuroendocrine Transdifferentiation in Prostate Cancer: An Opportunity for Intervention
Nouri, M; Ratther, E; Stylianou, N; Nelson, CC; Hollier, BG; Williams, ED
Front Immunol 2014-12-23 6.00 | Jan 9
Targeting Heat Shock Proteins in Metastatic Castration-Resistant Prostate Cancer
Azad, AA; Zoubeidi, A; Gleave, ME; Chi, KN
Nat Rev Urol 2014-12-16 5.48 | Dec 19
Immunotherapy in Prostate Cancer: Review of the Current Evidence
Fernández-García, EM; Vera-Badillo, FE; Perez-Valderrama, B; Matos-Pita, AS; Duran, I
Clin Transl Oncol 2014-12-06 5.47 | Dec 12
Advances in Systemic Therapies for Metastatic Castration-Resistant Prostate Cancer
Pant, MK; Abughaban, A; Aragon-Ching, JB
Future Oncol 2014-11-01 5.46 | Dec 5
Role of the Staphylococcal Nuclease and Tudor Domain Containing 1 in Oncogenesis
Jariwala, N; Rajasekaran, D; Srivastava, J; Gredler, R; Akile, MA; Robertson, CL; Emdad, L; Fisher, PB; Sarkar, D
Int J Oncol 2014-11-18 5.45 | Nov 28
The Epigenetics of Prostate Cancer Diagnosis and Prognosis: Update on Clinical Applications
Blute, ML Jr; Damaschke, NA; Jarrard, DF
Curr Opin Urol 2014-11-15 5.44 | Nov 21
Genomic Rearrangements in Prostate Cancer
Barbieri, CE; Rubin, MA
Curr Opin Urol 2014-11-12 5.43 | Nov 14
Models of Neuroendocrine Prostate Cancer
Berman-Booty, LD; Knudsen, K
Endocr Relat Cancer 2014-10-27 5.42 | Nov 7
Androgens and Androgen Receptor Signaling in Prostate Tumorigenesis
Zhou, Y; Bolton, E; Jones, JO
J Mol Endocrinol 2014-10-28 5.41 | Oct 31
Revisiting STAT3 Signaling in Cancer: New and Unexpected Biological Functions
Yu, H; Lee; H; Herrmann, A; Buettner, R; Jove, R
Nat Rev Cancer 2014-10-24 5.40 | Oct 24
MTA Family of Proteins in Prostate Cancer: Biology, Significance, and Therapeutic Opportunities
Levenson, AS; Kumar, A; Zhang, X
Cancer Metastasis Rev 2014-10-22 5.40 | Oct 24
Lactate Transporters in the Context of Prostate Cancer Metabolism: What Do We Know?
Pértega-Gomes, N; Baltazar, F
Int J Mol Sci 2014-10-13 5.39 | Oct 17
Secreted Phospholipases A2 in Cancer: Diverse Mechanisms of Action
Brglez, V; Lambeau, G; Petan, T
Biochimie 2014-10-05 5.38 | Oct 10
Safety of Antiandrogen Therapy for Treating Prostate Cancer
Ricci, F; Buzzatti, G; Rubagotti, A; Boccardo, F
Expert Opin Drug Saf 2014-10-01 5.37 | Oct 3
Epithelial Plasticity in Prostate Cancer: Principles and Clinical Perspectives
Ras, R; Gregory, PA; Hollier, BG; Tilley, WD; Selth, LA
Trends Mol Med 2014-09-25 5.37 | Oct 3
5-Alpha-Reductase Inhibitors in Diseases of the Prostate
Carrasquillo, RJ; Nealy, SW; Wang, DS
Curr Opin Endocrinol Diabetes Obes 2014-09-27 5.37 | Oct 3
Bone-Targeting Radiopharmaceuticals for the Treatment of Bone-Metastatic Castration-Resistant Prostate Cancer: Exploring the Implications of New Data
Ryan, CJ; Saylor, PJ; Everly, JJ; Sartor, O
Oncologist 2014-09-17 5.36 | Sep 26
Emerging Mechanisms of Enzalutamide Resistance in Prostate Cancer
Claessens, F; Helsen, C; Prekovic, S; Van den Broeck, T; Slans, L; Van Poppel, H; Joniau, S
Nat Rev Urol 2014-09-16 5.35 | Sep 19
Genetic Variation: Effect on Prostate Cancer
Sissung, TM; Price, DK; Del Re, M; Ley, AM; Giovannetti, E; Figg, WD; Danesi, R
Biochim Biophys Acta 2014-09-06 5.34 | Sep 12
Therapeutic Vaccines as a Promising Treatment Modality against Prostate Cancer: Rationale and Recent Advances
Singh, BH; Gulley, JL
Ther Adv Vaccines 2014-09-01 5.33 | Sep 5
SLCO and ABC Transporters: A Role for Steroid Transport in Prostate Cancer Progression
Cho, E; Montgomery, RB; Mostaghel, EA
Endocrinology 2014-08-22 5.32 | Aug 29
Pomegranate and Its Components as Alternative Treatment for Prostate Cancer
Wang, L; Martins-Green, M
Int J Mol Sci 2014-08-19 5.32 | Aug 29
NUMB Inhibition of NOTCH Signaling as a Therapeutic Target in Prostate Cancer
Flores, AN; McDermott, N; Meunier, A; Marignol, L
Nat Rev Urol 2014-08-19 5.31 | Aug 22
DNA Damage Response and Prostate Cancer: Defects, Regulation and Therapeutic Implications
Karanika, S; Karantanos, T; Li, L; Corn, PG; Thompson, TC
Oncogene 2014-08-18 5.31 | Aug 22
Autophagy as a Modulator and Target in Prostate Cancer
Farrow, JM; Yang, JC; Evans, CP
Nat Rev Urol 2014-08-19 5.31 | Aug 22
Strategies for Targeting the Androgen Receptor Axis in Prostate Cancer
Carver, BS
Drug Discov Today 2014-08-10 5.30 | Aug 15
The Convergence of DNA Damage Checkpoint Pathways and Androgen Receptor Signaling in Prostate Cancer
Ta, HQ; Gioeli, D
Endocr Relat Cancer 2014-08-05 5.29 | Aug 8
Evolving Therapeutic Concepts in Prostate Cancer Based on Genome-Wide Analyses
Duensin, S; Hohenfellner, M; Pahernik, S; Sültmann, H; Roth, W; Grüllich, C; Hadaschik; Korzeniewski, N; Georgi, B
Int J Oncol 2014-07-28 5.28 | Aug 1
Personalizing Prostate Cancer Therapy: The Way Forward
Cetnar, JP; Beer, TM
Drug Discovery Today 2014-07-18 5.27 | Jul 25
The Role of Estrogen Receptor Beta in Prostate Cancer
Christoforou, P; Christopoulos, PF; Koutsilieris, M
Mol Med 2014-07-14 5.26 | Jul 18
Pathology Consultation on Prostate-Specific Antigen Testing
Fantz, C; Noguez, J
Am J Clin Pathol 2014-07-01 5.25 | Jul 11
Uncovering the Roles of miRNAs and Their Relationship with Androgen Receptor in Prostate Cancer
ChunJiao, S; Huan, C; ChaoYang, X; GuoMei, R
IUBMB Life 2014-06-30 5.24 | Jul 4
The Role of MicroRNA in Castration-Resistant Prostate Cancer
Thieu, W; Tilki, D; deVere White, RW; Evans, CP
Urol Oncol 2014-07-01 5.23 | Jun 27
Glycans and Galectins in Prostate Cancer Biology, Angiogenesis and Metastasis
Compagno, D; Gentilini, LD; Jaworski, FM; Gonzalez Perez, I; Contrufo, G; Laderach, D
Glycobiology 2014-06-16 5.22 | Jun 20
Androgen Receptor: Structure, Role in Prostate Cancer and Drug Discovery
Tan, MH; Li, J; Xu, H; Melcher, K; Yong, EL
Acta Pharmacologica Sinica 2014-06-09 5.21 | Jun 13
Beyond Androgen Deprivation Ancillary Integrative Strategies for Targeting the Androgen Receptor Addiction of Prostate Cancer
McCarty, MF; Hejazi, J; Rastmanesh, R
Integr Cancer Ther 2014-05-26 5.20 | Jun 6
High-Risk Prostate Cancer – Classification and Therapy
Chang, AJ; Autio, KA; Roach, M 3rd; Scher, HI
Nat Rev Clin Oncol 2014-05-20 5.19 | May 30
Evolution of Androgen Receptor Targeted Therapy for Advanced Prostate Cancer
Wong, YNS; Ferraldeschi, R; Attard, G; de Bono, J
Nat Rev Clin Oncol 2014-05-20 5.18 | May 23
Targeting the Androgen Receptor Pathway in Castration-Resistant Prostate Cancer: Progresses and Prospects
Ferraldeschi, R; Welti, J; Luo, J; Attard, G; de Bono, JS
Oncogene 2014-05-19 5.18 | May 23
Vaccine Immunotherapy for Prostate Cancer: From Mice to Men
Lubaroff, DM; Vaena, D; Brown, JA; Zehr, P; Griffith KC; Brown, E; Eastman J; Nepple, K; Kattula, A; Williams, RD
Immunol Res 2014-05-22 5.18 | May 23
Circulating Tumor Cells—Monitoring Treatment Response in Prostate Cancer
Miyamoto, DT; Sequist, LV; Lee, RJ
Nat Rev Clin Oncol 2014-05-13 5.17 | May 16
In Vitro Modeling of the Prostate Cancer Microenvironment
Ellem, SJ; De-Juan-Pardo, EL; Risbridger, GP
Adv Drug Deliv Rev 2014-05-09 5.17 | May 16
The Link between Androgen Receptor Splice Variants and Castration-Resistant Prostate Cancer
Sprenger, CCT; Plymate, SR
Horm Cancer 2014-05-06 5.16 | May 9
Restoring TGFβ1 Pathway-Related MicroRNAs: Possible Impact in Metastatic Prostate Cancer Development
Santos, JI; Teixeira, AL; Dias, F; Gomes, M; Nogueira, A; Assis, J; Medeiros, R
Tumor Biol 2014-04-25 5.15 | May 2
Concept and Viability of Androgen Annihilation for Advanced Prostate Cancer
Mohler, JL
Cancer 2014-04-25 5.15 | May 2
Androgen Synthesis Inhibitors in the Treatment of Castration-Resistant Prostate Cancer
Stein, MN; Patel, N; Bershadskiy, A; Sokoloff, A; Singer, EA
Asian J Androl 2014-04-06 5.14 | Apr 25
Reconsideration of Progression to CRPC during Androgen Deprivation Therapy
Mizokami, A; Namiki, M
J Steroid Biochem Mol Biol 2014-04-06 5.13 | Apr 11
Overdetection in Screening for Prostate Cancer
Hugosson, J; Carlsson, S
Curr Opin Urol 2014-03-25 5.12 | Apr 4
Novel Bone-Targeting Agents in Prostate Cancer
Albany, C; Hahn, NM
Prostate Cancer Prostatic Dis 2014-03-25 5.11 | Mar 28
Androgen Receptor Antagonists for Prostate Cancer Therapy
Helsen, C; Van der Broeck, T; Voet, A; Prekovic, S; Van Poppel, H; Joniau, S; Claessens, F
Endocr Relat Cancer 2014-03-17 5.11 | Mar 28
TGF-β Cascade Regulation by PPP1 and Its Interactors – Impact on Prostate Cancer Development and Therapy
Korrodi-Gregorio, L; Silva, JV; Snatos-Sousa, L; Freitas, MJ; Felgueiras, J; Fardilha, M
J Cell Mol Med 2014-03-15 5.10 | Mar 21
Biomarkers in Prostate Cancer: What’s New?
Sartori, DA; Chan, DW
Curr Opin Oncol 2014-03-12 5.10 | Mar 21
Contributions of Epithelial-Mesenchymal Transition and Cancer Stem Cells to the Development of Castration Resistance of Prostate Cancer
Li, P; Yang, R; Gao, WQ
Mol Cancer 2014-03-12 5.09 | Mar 14
PPARγ vs TR4 Nuclear Receptor Differential Roles in Prostate Cancer and Metabolic Diseases
Liu, S; Lin, SJ; Li, G; Kim, E; Chen, YT; Yang, D; Tan, E; Yong, EL; Cai, X; Chang, C
Endocr Relat Cancer 2014-03-12 5.09 | Mar 14
Current Trends for the Use of Androgen Deprivation Therapy in Conjunction with Radiotherapy for Patients with Unfavorable Intermediate-Risk, High-Risk, Localized, and Locally Advanced Prostate Cancer
Roach III, M
Cancer 2014-03-03 5.08 | Mar 7
The Proteomics of Prostate Cancer Exosomes
Drake, RR; Kislinger, T
Expert Rev Proteomics 2014-02-25 5.07 | Feb 28
Small Cell Carcinoma of the Prostate
Nadal, R; Schweizer, M; Kryvenko, ON; Epstein, JI; Eisenberger, MA
Nat Rev Urol 2014-02-18 5.06 | Feb 21
Src Signaling Pathways in Prostate Cancer
Varkaris, A; Katsiampoura, AD; Araujo, JC; Gallick, GE; Corn, PG
Cancer Metastasis Rev 2014-02-13 5.05 | Feb 14
Targeting Metastatic Castration-Resistant Prostate Cancer: Mechanisms of Progression and Novel Early Therapeutic Approaches
Cereda, V; Formica, V; Massimiani, G; Tosetto, L; Roselli, M
Expert Opin Investig Drugs 2014-02-03 5.04 | Feb 7
Immunotherapy for Prostate Cancer: Recent Developments and Future Challenges
Schweizer, MT; Drake, CG
Cancer Metastasis Rev 2014-01-30 5.03 | Jan 31
Statins: Protectors or Pretenders in Prostate Cancer?
Moon, H; Hill, MM; Roberts, MJ; Gardiner, RA; Brown, AJ
Trends Endocrinol Metab 2014-01-22 5.02 | Jan 24
Emerging Roles of Radioresistance in Prostate Cancer Metastasis and Radiation Therapy
Chang, L; Graham, PH; Hao, J; Bucci, J; Cozzi, PJ; Kearsley, JH; Li, Y
Cancer Metastasis Rev 2014-01-21 5.02 | Jan 24
Metastatic Castration-Resistant Prostate Cancer (CRPC): Preclinical and Clinical Evidence for the Sequential Use of Novel Therapeutics
Mukherji, D; Omlin, A; Pezaro, C; Shamseddine, A; de Bono, J
Cancer Metastasis Rev 2014-01-23 5.02 | Jan 24
Insulin-Like Growth Factor Receptor-1 (IGF-IR) as a Target for Prostate Cancer Therapy
Wu, J; Yu, E
Cancer Metastasis Rev 2014-01-12 5.01 | Jan 17
Androgen Receptor Signaling in Prostate Cancer
Culig, Z; Santer, FR
Cancer Metastasis Rev 2014-01-03 5.00 | Jan 10
Estrogen Receptor Beta in Prostate Cancer: Friend or Foe?
Nelson, AW; Tilley, WD; Neal, DE; Carroll, J
Endocr Relat Cancer 2014-01-08 5.00 | Jan 10
Prostate Cancer: From the Pathophysiologic Implications of Some Genetic Risk Factors to Translation in Personalized Cancer Treatments
Balistreri, CR; Candore, G; Lio, D; Carruba, G
Cancer Gene Ther 2014-01-10 5.00 | Jan 10
Molecular Pathology and Prostate Cancer Therapeutics: From Biology to Bedside
Nava Rodrigues, DN; Butler, LM; Lorente Estelles, D; de Bono, JS
J Pathol 2013-12-10 4.49 | Dec 20
The Prostate-Specific Membrane Antigen: Lessons and Current Clinical Implications from 20 Years of Research
Ristau, BT; O’Keefe, DS; Bacich, DJ
Urol Oncol 2013-12-09 4.48 | Dec 13
Circulating Tumor Cells in Prostate Cancer
Hu, B; Rochefort, H; Goldkorn, A
Cancers 2013-12-04 4.48 | Dec 13
Abiraterone Acetate: A Review of Its Use in Patients with Metastatic Castration-Resistant Prostate Cancer
Hoy, SM
Drugs 2013-12-01 4.47 | Dec 6
Future Directions in the Prevention of Prostate Cancer
Thompson Jr, IM; Cabang, AB; Wargovich, MJ
Nat Rev Clin Oncol 2013-11-26 4.46 | Nov 29
Metastatic Castration-Resistant Prostate Cancer: New Therapies, Novel Combination Strategies and Implications for Immunotherapy
Drake, CG; Sharma, P; Gerritsen, W
Oncogene 2013-11-25 4.46 | Nov 29
Diethylstilboestrol for the Treatment of Prostate Cancer: Past, Present and Future
Turo, R; Smolski, M; Esler, R; Kujawa, ML; Bromage, SJ; Oakley, N; Adeyoju, A; Brown, SCW; Brough, R; Sinclair, A; Collins, GN
Scand J Urol 2013-11-21 4.45 | Nov 22
The Hurdle of Antiandrogen Drug Resistance: Drug Design Strategies
Trendel, JA
Expert Opin Drug Discov 2013-11-09 4.44 | Nov 15
Clinical Use of Novel Urine and Blood Based Prostate Cancer Biomarkers: A Review
Dijkstra, S; Mulders, PFA; Schalken, JA
Clin Biochem 2013-10-29 4.43 | Nov 8
Disruption of Prostate Epithelial Differentiation Pathways and Prostate Cancer Development
Frank, SB; Miranti, CK
Front Oncol 2013-10-31 4.43 | Nov 8
Androgen Receptor Co-Regulatory Networks in Castration Resistant Prostate Cancer
Cheung, E; Sung, YY
Endocr Relat Cancer 2013-10-23 4.42 | Nov 1
Chemotherapeutic Inhibitors in the Treatment of Prostate Cancer
Deshmukh, RR; Schmitt, SM; Hwang, C; Dou, QP
Expert Opin Pharmacother 2013-10-25 4.42 | Nov 1
Non-Coding RNAs in Prostate Cancer: The Long and the Short of It
Bolton, EM; Tuzova, AV; Walsh, AL; Lynch, T; Perry, AS
Clin Cancer Res 2013-10-21 4.41 | Oct 25
Enzalutamide: A Review of Its Use in Metastatic, Castration-Resistant Prostate Cancer
Sanford, M
Drugs 2013-10-01 4.40 | Oct 18
Beyond Abiraterone: New Hormonal Therapies for Metastatic Castration-Resistant Prostate Cancer
Pinto, A
Cancer Biol Ther 2013-10-07 4.39 | Oct 11
Molecular Imaging of Prostate Cancer with PET
Jadvar, H
J Nucl Med 2013-10-01 4.38 | Oct 4
Genomic Rearrangements of PTEN in Prostate Cancer
Phin, S; Moore, MW; Cotter, PD
Front Oncol 2013-09-27 4.37 | Sep 27
TRAIL and MicroRNAs in the Treatment of Prostate Cancer: Therapeutic Potential and Role of Nanotechnology
Farooqi, AA; De Rosa, G
Appl Microbiol Biotechnol 2013-09-15 4.36 | Sep 20
Intraductal Carcinoma of the Prostate: The Whole Story
Zhou, M
Pathology 2013-10-01 4.35 | Sep 19
Mechanisms of Androgen Receptor Activation in Castration-Resistant Prostate Cancer
Sharifi, N
Endocrinology 2013-09-03 4.34 | Sep 12
Epigenetic Susceptibility Factors for Prostate Cancer with Aging
Damaschke, NA; Yang, B; Bhusari, S; Svaren, JP; Jarrard, DF
Prostate 2013-09-02 4.34 | Sep 12
Genome-Wide Association Studies on Prostate Cancer: The End or the Beginning?
Chen, R; Ren, S; Sun, Y
Protein Cell 2013-08-27 4.33 | Sep 5
Salvage Therapy of Intraprostatic Failure after Radical External-Beam Radiotherapy for Prostate Cancer: A Review
Alongi, F; De Bari, B; Campostrini, F; Arcangeli, S; Matei, DV; Lopci, E; Petralia, G; Bellomi, M; Chiti, A; Magrini, SM; Scorsetti, M; Orecchia, R; Jereczek-Fossa, BA
Crit Rev Oncol Hematol 2013-08-14 4.32 | Aug 23
Caveola-Forming Proteins Caveolin-1 and PTRF in Prostate Cancer
Nassar, ZD; Hill, MM; Parton, RG; Parat, MO
Nat Rev Urol 2013-08-13 4.31 | Aug 16
Dietary Antioxidants and Prostate Cancer: A Review
Vance, TM; Su, J; Fontham, ET; Koo, SI; Chun, OK
Nutr Cancer 2013-08-02 4.30 | Aug 9
Experimental Evidence of Persistent Androgen-Receptor-Dependency in Castration-Resistant Prostate Cancer
Kobayashi, T; Inoue, T; Kamba, T; Ogawa, O
Int J Mol Sci 2013-07-26 4.29 | Aug 2
A Road Map to Comprehensive Androgen Receptor Axis Targeting for Castration-Resistant Prostate Cancer
Mitsiades, N
Cancer Res 2013-07-25 4.28 | Jul 26
Cell Mates: Paracrine and Stromal Targets for Prostate Cancer Therapy
Sluka, P; Davis, ID
Nat Rev Urol 2013-07-16 4.27 | Jul 19
The Potential Role of Lycopene for the Prevention and Therapy of Prostate Cancer: From Molecular Mechanisms to Clinical Evidence
Holzapfel, NP; Holzapfel, BM; Champ, S; Feldthusen, J; Clements, J; Hutmacher, DW
Int J Mol Sci 2013-07-12 4.27 | Jul 19
The Utility of Prostate-Specific Antigen in the Management of Advanced Prostate Cancer
Crawford, ED; Bennett, CL; Andriole, GL; Garnick, MB; Petrylak, DP
BJU Int 2013-07-04 4.26 | Jul 12
Perspectives on the Role of Isoflavones in Prostate Cancer
Ahmad, A; Biersack, B; Li, Y; Bao, B; Kong, D; Ali, S; Banerjee, S; Sarkar, FH
AAPS J 2013-07-04 4.25 | Jul 5
Phytochemicals from Cruciferous Vegetables; Epigenetics; and Prostate Cancer Prevention
Watson, GW; Beaver, LM; Williams, DE; Dashwood, RH; Ho, E
AAPS J 2013-06-26 4.24 | Jun 28
Overview of the Latest Treatments for Castration-Resistant Prostate Cancer
Bishr, M; Saad, F
Nat Rev Urol 2013-06-25 4.24 | Jun 28
Searching for Prostate Cancer Stem Cells: Markers and Methods
Sharpe, B; Beresford, M; Bowen, R; Mitchard, J; Chalmers, AD
Stem Cell Rev 2013-10-01 4.23 | Jun 21
Prostate Cancer Progression after Androgen Deprivation Therapy: Mechanisms of Castrate Resistance and Novel Therapeutic Approaches
Karantanos, T; Corn, PG; Thompson, TC
Oncogene 2013-06-10 4.22 | Jun 14
Androgen Receptor Functions in Castration-Resistant Prostate Cancer and Mechanisms of Resistance to New Agents Targeting the Androgen Axis
Yuan, X; Cai, C; Chen, S; Chen, S; Yu, Z; Balk, SP
Oncogene 2013-06-10 4.22 | Jun 14
Defining the Threshold for Significant versus Insignificant Prostate Cancer
Van der Kwast, TH; Roobol, MJ
Nat Rev Urol 2013-05-28 4.21 | Jun 7
Hypoxia; Notch Signaling; and Prostate Cancer
Marignol, L; Rivera-Figueroa, K; Lynch, T; Hollywood, D
Nat Rev Urol 2013-05-28 4.20 | May 31
Intermittent Versus Continuous Androgen Deprivation Therapy in Advanced Prostate Cancer
Klotz, L
Curr Urol Rep 2013-06-01 4.19 | May 24
Oxidative Stress in Prostate Cancer: Changing Research Concepts towards a Novel Paradigm for Prevention and Therapeutics
Paschos, A; Pandya, R; Duivenvoorden, WC; Pinthus, JH
Prostate Cancer P D 2013-05-14 4.18 | May 17
Molecular Aspects of Androgenic Signaling and Possible Targets for Therapeutic Intervention in Prostate Cancer
Culig, Z; Santer, FR
Steroids 2013-04-30 4.17 | May 10
Circulating MicroRNAs As Potential New Biomarkers for Prostate Cancer
Sita-Lumsden, A; Dart, DA; Waxman, J; Bevan, CL
Brit J Cancer 2013-04-30 4.16 | May 3
Dormancy in Solid Tumors: Implications for Prostate Cancer
Ruppender, NS; Morrissey, C; Lange, PH; Vessella, RL
Cancer Metastasis Rev 2013-04-24 4.15 | Apr 26
Minireview: Androgen Metabolism in Castration-Resistant Prostate Cancer
Sharifi, N
Mol Endocrinol 2013-04-16 4.14 | Apr 19
Molecular Mechanisms of Silibinin-Mediated Cancer Chemoprevention with Major Emphasis on Prostate Cancer
Ting, H; Deep, G; Agarwal, R
AAPS J 2013-04-16 4.14 | Apr 19
Advancing Precision Medicine for Prostate Cancer through Genomics
Roychowdhury, S; Chinnaiyan, AM
J Clin Oncol 2013-04-15 4.14 | Apr 19
Prostate Cancer Risk-Associated Genetic Markers and Their Potential Clinical Utility
Xu, J; Sun, J; Zheng, SL
Asian J Androl 2013-04-08 4.13 | Apr 12
Role of Androgen and Vitamin D Receptors in Endothelial Cells from Benign and Malignant Human Prostate
Godoy, AS; Chung, I; Montecinos, VP; Buttyan, R; Johnson, CS; Smith, GJ
Am J Physiol-Endoc M 2013-04-02 4.12 | Apr 5
Delivering RNAi Therapeutics with Non-Viral Technology: A Promising Strategy for Prostate Cancer?
Guo, J; Evans, JC; O’Driscoll, CM
Trends Mol Med 2013-03-14 4.11 | Mar 22
Zinc Transporters in Prostate Cancer
Franz, MC; Anderle, P; Bürzle, M; Suzuki, Y; Freeman, MR; Hediger, MA; Kovacs, G
Mol Aspects Med 2013-03-16 4.11 | Mar 22
Roles of MicroRNAs during Prostatic Tumorigenesis and Tumor Progression
Fang, YX; Gao, WQ
Oncogene 2013-03-04 4.10 | Mar 15
Validation and Clinical Utility of Prostate Cancer Biomarkers
Scher, HI; Morris, MJ; Larson, S; Heller, G
Nat Rev Clin Oncol 2013-03-05 4.09 | Mar 8
Proteomic Studies of Urinary Biomarkers for Prostate; Bladder and Kidney Cancers
Wood, SL; Knowles, MA; Thompson, D; Selby, PJ; Banks, RE
Nat Rev Urol 2013-02-26 4.08 | Mar 1
Proposed Mechanisms of Action for Prostate Cancer Vaccines
Geary, SM; Lemke, CD; Lubaroff, DM; Salem, AK
Nat Rev Urol 2013-02-12 4.07 | Feb 22
Eph Receptors and Their Ligands: Promising Molecular Biomarkers and Therapeutic Targets in Prostate Cancer
Lisle, JE; Mertens-Walker, I; Rutkowski, R; Herington, AC; Stephenson, SA
Biochim Biophys Acta 2013-02-08 4.06 | Feb 15
Local Endocrine; Paracrine and Redox Signaling Networks Impact Estrogen and Androgen Crosstalk in the Prostate Cancer Microenvironment
Grubisha, MJ; DeFranco, DB
Steroids 2013-02-01 4.05 | Feb 8
Manipulating the Epigenome for the Treatment of Urological Malignancies
O’Rourke, CJ; Knabben, V; Bolton, E; Moran, D; Lynch, T; Hollywood, D; Perry, AS
Pharmacol Ther 2013-01-24 4.04 | Feb 1
Androgen Receptor Antagonists in Castration-Resistant Prostate Cancer
Rathkopf, D; Scher, HI
Cancer J 2013-01-01 4.03 | Jan 25
Aberrant PSA Glycosylation – A Sweet Predictor of Prostate Cancer
Gilgunn, S; Conroy, PJ; Saldova, R; Rudd, PM; O’Kennedy, RJ
Nat Rev Urol 2013-01-15 4.02 | Jan 18
Gonadotropin-Releasing Hormone Receptors as Molecular Therapeutic Targets in Prostate Cancer: Current Options and Emerging Strategies
Limonta, P; Manea, M
Cancer Treat Rev 2013-01-03 4.01 | Jan 11
Proteomics Role in Prostate Cancer Biomarkers Discovery and Validation
Pin, E; Fredolini, C; Petricoin, EF 3rd
Clin Biochem 2012-12-22 4.00 | Jan 4
Adaptation or Selection—Mechanisms of Castration-Resistant Prostate Cancer
Zong, Y; Goldstein, AS
Nat Rev Urol 2013-02-01 3.49 | Dec 21
Brain Metastases from Prostate Cancer: An Emerging Clinical Problem with Implications for the Future Therapeutic Scenario
Caffo, O; Veccia, A; Russo, L; Galligioni, E
Future Oncol 2012-12-01 3.48 | Dec 14
Sequencing the Transcriptional Network of Androgen Receptor in Prostate Cancer
Chng, KR; Cheung, E
Cancer Lett 2012-11-27 3.47 | Dec 7
Cells of Origin for Cancer: An Updated View from Prostate Cancer
Xin, L
Oncogene 2012-11-26 3.46 | Nov 30
Defective DNA Repair Systems and the Development of Breast and Prostate Cancer
Kitagishi, Y; Kobayashi, M; Matsuda, S
Int J Oncol 2012-11-14 3.45 | Nov 23
The Complexity of Prostate Cancer: Genomic Alterations and Heterogeneity
Boyd, LK; Mao, X; Lu, YJ
Nat Rev Urol 2013-11-01 3.44 | Nov 16
Modeling Prostate Cancer in Mice: Something Old; Something New; Something Premalignant; Something Metastatic
Irshad, S; Abate-Shen, C
Cancer Metastasis Rev 2013-06-01 3.43 | Nov 9
Progress in Emerging Therapies for Advanced Prostate Cancer
Oudard, S
Cancer Treat Rev 2012-10-26 3.42 | Nov 2
Characterization of Tumor Differentiation Factor (TDF) and Its Receptor (TDF-R)
Sokolowska, I; Woods, AG; Gawinowicz, MA; Roy, U; Darie, CC
Cell Mol Life Sci 2012-10-16 3.41 | Oct 26
Systematic Review and Meta-Analysis of COX-2 Expression and Polymorphisms in Prostate Cancer
Shao, N; Feng, N; Wang, Y; Mi, Y; Li, T; Hua, L
Mol Bio Rep 2012-10-07 3.40 | Oct 19
Benign Prostate Hyperplasia and Stem Cells: A New Therapeutic Opportunity
Notara, M; Ahmed, A
Cell Biol Toxicol 2012-10-12 3.40 | Oct 19
The Roots of Cancer: Stem Cells and the Basis for Tumor Heterogeneity
Shibata, M; Shen, MM
Bioessays 2012-10-02 3.39 | Oct 12
Pro-Survival and Anti-Apoptotic Properties of Androgen Receptor Signaling by Oxidative Stress Promote Treatment Resistance in Prostate Cancer
Shiota, M; Yokomizo, A; Naito, S
Endocr Relat Cancer 2012-10-02 3.39 | Oct 12
Abiraterone and Novel Antiandrogens: Overcoming Castration Resistance in Prostate Cancer
Ferraldeschi, R; Pezaro, C; Karavasilis, V; de Bono, J
Annu Rev Med 2012-09-27 3.38 | Oct 5
Prostate Cancer-From Steroid Transformations to Clinical Translation
Chang, KH; Sharifi, N
Nat Rev Urol 2012-10-02 3.38 | Oct 5
Why Imatinib Remains an Exception of Cancer Research
Horne, SD; Stevens, JB; Abdallah, BY; Liu, G; Bremer, SW; Ye, CJ; Heng, HH
J Cell Physiol 2012-09-27 3.38 | Oct 5
Non-Metastatic CRPC and Asymptomatic Metastatic CRPC: Which Treatment for Which Patient?
Tombal, B
Ann Oncol 2012-09-28 3.37 | Sep 28
Androgen Receptor on the Move: Boarding the Microtubule Expressway to the Nucleus
Thadani-Mulero, M; Nanus, DM; Giannakakou, P
Cancer Res 2012-09-15 3.36 | Sep 21
Targeting the Androgen Receptor Signalling Axis in Castration-Resistant Prostate Cancer
Tsao, CK; Galsky, MD; Small, AC; Yee, T; Oh, WK
BJU Int 2012-09-18 3.36 | Sep 21
A Perspective on the Role of Estrogen in Hormone-Induced Prostate Carcinogenesis
Bosland, MC
Cancer Lett 2012-08-29 3.35 | Sep 14
Angiogenesis in Prostate Cancer: Onset; Progression and Imaging
Russo, G; Mischi, M; Scheepens, W; De la Rosette, JJ; Wijkstra, H
BJU Int 2012-09-07 3.34 | Sep 7
The Reactive Stroma Microenvironment and Prostate Cancer Progression
Barron, DA; Rowley, DR
Endocr Relat Cancer 2012-08-28 3.33 | Aug 31
Medical Strategies for Treatment of Castration Resistant Prostate Cancer (CRPC) Docetaxel Resistant
Altavilla, A; Iacovelli, R; Procopio, G; Alesini, D; Risi, E; Campennì, GM; Palazzo, A; Cortesi, E
Cancer Biol Ther 2012-07-24 3.32 | Aug 24
Patterns of Outcome and Toxicity after Salvage Prostatectomy; Salvage Cryosurgery and Salvage Brachytherapy for Prostate Cancer Recurrences after Radiation Therapy: A Multi-Center Experience and Literature Review
Peters, M; Moman, MR; van der Poel, HG; Vergunst, H; de Jong, IJ; Vijverberg, PL; Battermann, JJ; Horenblas, S; van Vulpen, M
World J Urol 2012-08-18 3.32 | Aug 24